CytomX Therapeutics (6C1) Cash flow

6 Followers

CytomX Therapeutics Cash Flow

DE:6C1's free cash flow for Q2 2026 was $-18.07M. For the 2026 fiscal year, DE:6C1's free cash flow was decreased by $10.73M and operating cash flow was $-18.07M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -75.59M	$ -86.23M	$ -56.03M	$ -110.79M	$ -119.03M
Investing Cash Flow	$ -59.74M	$ 99.70M	$ -150.67M	$ 98.26M	$ 22.49M
Financing Cash Flow	$ 110.45M	$ 7.52M	$ 30.23M	$ 648.00K	$ 110.21M
End Cash Position	$ 14.19M	$ 39.08M	$ 17.17M	$ 194.57M	$ 206.45M
Free Cash Flow	$ -75.81M	$ -86.54M	$ -56.88M	$ -112.53M	$ -120.64M

Currency in USD